41 studies found for:    "Sleep Disorders, Circadian Rhythm"
Show Display Options
Rank Status Study
21 Recruiting Safety Study of Tasimelteon for Treatment of Non-24-Hour-Sleep-Wake Disorder in Blind Individuals With No Light Perception
Condition: Non 24 Hour Sleep Wake Disorder
Intervention: Drug: tasimelteon
22 Recruiting Fire Fighter Fatigue Management Program: Operation Fight Fatigue
Conditions: Shift-Work Sleep Disorder;   Insomnia;   Restless Leg Syndrome;   Obstructive Sleep Apnea;   Impaired Driving
Interventions: Behavioral: Sleep health education provided via a web-based program;   Other: Sleep disorder detection and treatment;   Other: Optimization of Sleep in Fire Station
23 Completed
Has Results
Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder
Conditions: Narcolepsy;   Sleep Apnea, Obstructive;   Sleep Apnea Syndromes;   Shift-Work Sleep Disorder
Intervention: Drug: CEP-10953 (Armodafinil)
24 Recruiting Cardiometabolic Risk of Shiftwork
Conditions: Sleep Deprivation;   Circadian Dysregulation;   Shift-Work Sleep Disorder
Intervention:
25 Active, not recruiting Fire Fighter Fatigue Management Program: Operation Stay Alert
Conditions: Shift-Work Sleep Disorder;   Insomnia;   Restless Leg Syndrome;   Obstructive Sleep Apnea;   Impaired Driving
Intervention: Other: sleep disorders screening
26 Completed Does Cognitive Behaviour Therapy (CBT) Improve the Effect of Light Therapy
Condition: Delayed Sleep Phase Syndrome
Interventions: Device: Light therapy and Cognitive behaviour therapy;   Device: Light therapy
27 Completed Sleepiness and Brain Function: The Effect of Armodafinil in Shift Work Sleep Disorder
Condition: Shift Work Sleep Disorder
Intervention:
28 Completed
Has Results
Extension Study of the Safety and Efficacy of Armodafinil in the Treatment of Patients With Excessive Sleepiness
Conditions: Excessive Daytime Sleepiness;   Narcolepsy;   Obstructive Sleep Apnea/Hypopnea Syndrome;   Chronic Shift Work Sleep Disorder
Intervention: Drug: Armodafinil 100 to 250 mg/day
29 Unknown  Circadian Rhythms and Sleep in Familial Delayed Sleep Phase Syndrome (DSPS) and Advanced Sleep Phase Syndrome (ASPS)
Condition: Sleep
Intervention:
30 Completed Sleep Enhancement Training Study for Experienced Shiftworkers
Condition: Shift-Work Sleep Disorder
Interventions: Behavioral: NIOSH shiftwork booklet;   Behavioral: Sleep Enhancement Training System
31 Completed Effects of Daytime Eszopiclone Administration in Shift Workers
Condition: Shift-Work Sleep Disorder
Interventions: Drug: eszopiclone;   Drug: matching placebo
32 Unknown  Synchronization and Desynchronization Between Circadian Rhythms in Patients With Delayed Sleep Phase Syndrome (DSPS)
Condition: Delayed Sleep Phase Syndrome
Intervention: Drug: Melatonin
33 Completed Sleep Enhancement Training Study for Novice Shiftworkers
Condition: Shift-Work Sleep Disorder
Interventions: Behavioral: Sleep Enhancement Training System;   Behavioral: NIOSH shiftwork booklet
34 Completed Efficacy and Safety of Circadin for Non-24 Hour Sleep-Wake Disorder in Totally Blind Subjects
Conditions: Non-24 Hour Sleep-Wake Disorder;   Blindness
Interventions: Drug: melatonin (Circadin);   Drug: placebo
35 Completed
Has Results
Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil and PROVIGIL
Condition: Chronic Shift Work Sleep Disorder
Interventions: Drug: PROVIGIL 200 mg;   Drug: Armodafinil 250 mg;   Drug: Armodafinil 200 mg;   Drug: Armodafinil 150 mg;   Drug: Placebo
36 Recruiting The Nuvigil and Provigil Pregnancy Registry
Conditions: Narcolepsy;   Obstructive Sleep Apnea;   Shift Work Sleep Disorder
Intervention: Drug: Modafinil/armodafinil
37 Completed Randomized Controlled Trial on the Treatment Effects of Melatonin and Light Therapy on Delayed Sleep Phase Syndrome
Condition: Delayed Sleep Phase Syndrome
Interventions: Dietary Supplement: Melatonin;   Other: Placebo melatonin;   Other: placebo light therapy;   Other: Light therapy
38 Completed
Has Results
Safety/Efficacy Study With Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Chronic SWSD
Conditions: Excessive Sleepiness;   Shift Work Sleep Disorder
Interventions: Drug: Armodafinil 150 mg/day;   Drug: Placebo
39 Completed Open Label Study to Assess the Absolute Bioavailability of Tasimelteon (HETLIOZ™)
Condition: Non-24-Hour-Sleep-Wake Disorder
Interventions: Drug: tasimelteon 20 mg capsule;   Drug: tasimelteon 2 mg I.V.
40 Completed Effects of Hydrocortisone, Melatonin, and Placebo on Jet Lag
Condition: Jet Lag Syndrome
Intervention: Drug: Melatonin

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-41) Show next page of results
Indicates status has not been verified in more than two years